Salubris Biotherapeutics, Inc. (SalubrisBio) is a science-driven biotechnology company dedicated to the discovery and global development of novel...
Salubris Biotherapeutics, Inc. (SalubrisBio) is a science-driven biotechnology company dedicated to the discovery and global development of novel therapeutics for the treatment of various diseases. The company was founded in 2014 by a team of experienced scientists and entrepreneurs with a shared vision to improve human health through innovative drug discovery.
At SalubrisBio, we are committed to developing safe and effective therapies that address unmet medical needs. Our research focuses on identifying new targets and pathways involved in disease progression, as well as developing innovative drug delivery systems that enhance therapeutic efficacy.
One of our key areas of focus is oncology, where we are developing a pipeline of novel cancer therapies that target specific molecular pathways involved in tumor growth and metastasis. Our lead candidate, SB-318, is a first-in-class small molecule inhibitor targeting the Wnt signaling pathway, which plays a critical role in cancer stem cell self-renewal and tumor initiation.
In addition to oncology, we are also actively pursuing research in other therapeutic areas such as immunology, neurology, and rare diseases. Our goal is to develop transformative therapies that have the potential to significantly improve patient outcomes and quality of life.
At SalubrisBio, we believe that collaboration is key to success in drug discovery. We work closely with academic institutions, contract research organizations (CROs), and other industry partners to advance our pipeline programs from preclinical development through clinical trials.
Our team consists of highly skilled scientists with expertise in medicinal chemistry, pharmacology, toxicology, biology,and clinical development.Our state-of-the-art facilities located at Suzhou Industrial Park enable us to conduct cutting-edge research using advanced technologies such as high-throughput screening (HTS), X-ray crystallography,and cryo-electron microscopy (cryo-EM).
We are committed not onlyto advancing scientific knowledge but also making it accessible globally.We have established partnerships with leading pharmaceutical companies worldwide for co-development or licensing agreements for our products.We aimto bring affordable medicines globally by partneringwith local manufacturersand distributorsin different countries aroundthe world.
In conclusion,Salubris Biotherapeuticsis an innovative biotech company dedicatedto discoveringanddevelopingnoveltherapiesfor patients suffering from various diseases.Our commitmenttowards scientific excellence,collaboration,and accessibility makes us stand out among othersin this field.We strive towards bringing hopeand improving livesgloballyby providingaffordablemedicinesfor all those who need them most.